P09.03 Activation of IL-22 signaling correlates with higher CD155 expression and stratifies poor outcomes of early-stage lung and breast cancer patients

Abstract

BackgroundCD155 (poliovirus receptor, PVR) is an immunosuppressive molecule overexpressed in lung adenocarcinoma (LUAD) and breast cancers (BRCA). However, no mutation has been identified that could be linked to such overexpression,...